Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. Radiotherapy Committee of the Danis
about
Cardio-oncology: Concepts and practicePostmastectomy radiation therapy: an overview for the practicing surgeonCardiac effects of anticancer therapy in the elderlySecond malignant neoplasms and cardiovascular disease following radiotherapy.Male breast cancer: 20-year survival data for post-mastectomy radiotherapy.Breast cancer (non-metastatic)Role of postmastectomy radiotherapy in early-stage (T1-2N0-1M0) triple-negative breast cancer: a systematic review.Adjuvant irradiation for breast cancer. Treatment plans need to be made with better anatomical information.Cardiovascular mortality after radiotherapy for breast cancer. Study showed only estimates of use of adjuvant radiotherapy.Adjuvant radiotherapy in breast cancer--the treatment of lymph node areas.Cardiovascular disease after cancer therapy.Modern radiotherapy for modern surgeons: an update on radiation oncology.Clinically apparent internal mammary nodal metastasis in patients with advanced breast cancer: incidence and local control.Role of radiotherapy in early breast cancer: an overview.Tangential beam IMRT versus tangential beam 3D-CRT of the chest wall in postmastectomy breast cancer patients: a dosimetric comparison.Cardiovascular event-free survival after adjuvant radiation therapy in breast cancer patients stratified by cardiovascular risk.Cardiac dose estimates from Danish and Swedish breast cancer radiotherapy during 1977-2001.Myocardial perfusion imaging with (99 m)Tc-tetrofosmin SPECT in breast cancer patients that received postoperative radiotherapy: a case-control studyClinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy.Risk of cardiac death after adjuvant radiotherapy for breast cancerBreast cancer: improving outcome following adjuvant radiotherapy.Should Postmastectomy Radiotherapy to the Chest Wall and Regional Lymph Nodes Be Standard for Patients with 1-3 Positive Lymph Nodes?Late Toxicity of Radiotherapy: A Problem or a Challenge for the Radiation Oncologist?Hypofractionated irradiation in elderly patients with breast cancer after breast conserving surgery and mastectomy : Analysis of 205 casesApplying innovations in surgical and radiation oncology to breast conservation therapy.The potential of proton beam radiation therapy in breast cancer.Optimizing locoregional control and survival for women with breast cancer: a review of current developments in postmastectomy radiotherapy.Myocardial infarction risk and tamoxifen therapy for breast cancerEvaluation of various boluses in dose distribution for electron therapy of the chest wall with an inward defect.Partial-breast irradiation: towards a replacement for whole-breast irradiation?Proton radiotherapy for chest wall and regional lymphatic radiation; dose comparisons and treatment delivery.Evaluation of cardiotoxicity five years after 2D planned, non-simulated, radiation therapy for left breast cancerCardiac mortality and morbidity after breast cancer treatment.Prospective surveillance and management of cardiac toxicity and health in breast cancer survivors.Progress and controversies: radiation therapy for invasive breast cancer.The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise.Reducing the Human Burden of Breast Cancer: Advanced Radiation Therapy Yields Improved Treatment Outcomes.Breast cancer therapy-associated cardiovascular disease.Radiation Toxicity to the Cardiovascular System.Long-term cardiovascular mortality after radiotherapy for breast cancer: A systematic review and meta-analysis.
P2860
Q26750878-62675A6D-0424-47A7-890C-5F2F495D03CDQ26823624-1173F7D4-589E-49CA-9B17-090BC3603AB9Q26863244-9C2472E0-8B0E-458B-A8A9-E571BED1FE98Q26864522-F40ABDEC-789C-4322-BF0B-9B598B318F7FQ30678712-8AE11AA8-A633-4F1B-9125-120D9946E16CQ33446778-226C11B4-8839-4F79-86A8-47208C1990B1Q33553668-3C72D0FF-1B17-4600-884C-7D4482FB1BB4Q33802889-A09A2D9E-7AAB-4454-B86E-978CC8C967A1Q33814894-F068FB5E-9DEE-452D-AC06-5ECC224BBB89Q34033287-8EE87A8A-391B-405A-A1A2-7121AEA9752CQ34604429-BCC5999A-521A-4BA6-9A16-7B006A597F51Q34695431-7FAF5787-B16B-4C9B-8E0D-DDE76B7A56E7Q34713794-91CD0501-1DF9-404D-B8D0-151AF457BACAQ34746826-51AEC9BE-C1A6-4D07-9F4D-D56E91462685Q34756411-C11CEC70-4E77-40E5-BB68-298D7D26132AQ34998564-70F12870-19F7-4CC7-ABB2-DE0D42549C70Q35201528-D22660EE-A5E7-4CD1-BDED-6FBB1345B54FQ35568774-40461367-43D7-44FE-8E96-22289F1A489CQ35743986-A30C292B-B40D-41D0-8D73-05B56754C736Q35754003-D366FE59-35FC-4855-B121-2CB76B3D6F8DQ35917880-F8A75F65-EB91-4B2C-BB4D-71BDE398B7C8Q35976078-23EF70F8-51EF-4556-8030-9F0B8921CC01Q35976168-E7C3B3AE-D421-472F-8FA8-D26E541ECDDCQ36010013-BB72CBD1-B8D8-4A92-93A7-A01445C4F116Q36051452-23DDB73E-F3EA-4507-A354-D7A87AAA9D17Q36333013-929D8FAA-26C5-467B-8ADF-2BEA5A79573EQ36381276-CF653086-62DB-45EF-A637-4AC21159B124Q36616900-4293EC5E-10B7-4A38-A02A-799497694933Q36696486-68A2B223-D365-4739-8B8F-792C6ED6A98FQ36731409-867CABA4-EE05-4920-8055-4EFA963DF6A6Q36769549-AAA765E3-8745-459E-9B99-163C4A8A2429Q37098183-771697F8-CD81-4DE2-8DA6-99B3E0C59352Q37123123-2258A109-A485-4B8C-831B-1026BC663491Q38001376-8484F4B6-AF42-4E8B-92A6-68DA5088F075Q38172886-AC83D6D8-E6EA-440E-9A04-7A7A6B0D97E3Q38426636-FEB4A08F-B278-4069-9C42-05BFB7E6646FQ38594113-6C4A7742-6EE6-462C-AFA3-3CF49B2FF17AQ38645182-094CE9F2-B947-47D1-AB4C-EDF51B0283DCQ38720780-A3D1BDB3-928D-4655-AC4D-2B88E8552476Q38752412-600E64D8-792B-4CB8-B1B3-595273EAC9FB
P2860
Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. Radiotherapy Committee of the Danis
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Morbidity and mortality of isc ...... therapy Committee of the Danis
@en
Morbidity and mortality of isc ...... therapy Committee of the Danis
@nl
type
label
Morbidity and mortality of isc ...... therapy Committee of the Danis
@en
Morbidity and mortality of isc ...... therapy Committee of the Danis
@nl
prefLabel
Morbidity and mortality of isc ...... therapy Committee of the Danis
@en
Morbidity and mortality of isc ...... therapy Committee of the Danis
@nl
P2093
P1433
P1476
Morbidity and mortality of isc ...... therapy Committee of the Danis
@en
P2093
J J Christensen
J Overgaard
M Overgaard
P304
P356
10.1016/S0140-6736(99)02245-X
P407
P577
1999-10-01T00:00:00Z